Tappan, NY, United States of America

Rajesh Kumar Kainthan

This inventor holds 25 USPTO granted patents and 10 published patent applications, plus 7 CIPO patents and 7 EPO patents, primarily in Glycoconjugate Chemistry. Top assignees: Pfizer Corporation, The University of British Columbia, Centre for Drug Research and Development. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajesh Kumar Kainthan. Retrieved from https://idiyas.com/inventor/rajesh-kumar-kainthan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 

% Patents Active = 76.0

 

 

Average Co-Inventor Count = 5.9

ph-index = 7

Forward Citations = 134(Granted Patents)


Location History:

  • Burnaby, CA (2016)
  • Cambridge, MA (US) (2017)
  • Tappan, NY (US) (2015 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Immunogenic Compositions
Glycoconjugation Process
Capsular Polysaccharides
Conjugated Antigens
Glycoprotein Conjugates
Derivatized Polyglycerols
Nucleic Acid Delivery
Serum Albumin Substitute
Protein Conjugates
Polysaccharide Conjugates
Immunogenic Glycoconjugates
Bioconjugation Techniques
25 patents (USPTO):Explore Patents

Title: The Innovative Mind of Rajesh Kumar Kainthan

Introduction: Rajesh Kumar Kainthan, based in Tappan, NY, is a notable inventor with a remarkable portfolio of 22 patents. His groundbreaking work predominantly focuses on immunogenic compositions and glycoconjugation processes, demonstrating his commitment to advancing medical science and public health.

Latest Patents: Among his latest innovations is a patent for the "Glycoconjugation process," which involves methods for preparing glycoconjugates that combine saccharides with carrier proteins using stable nitroxyl radicals as oxidizing agents. This patent contributes to the development of immunogenic compositions featuring glycoconjugates for potential use in vaccines. Another significant patent is for "Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof." This invention introduces novel immunogenic compositions that contain glycoconjugates from serotypes not included in existing vaccines such as PREVNAR® and SYNFLORIX®, thus broadening the possibilities for vaccination against pneumococcal infections in vulnerable populations including infants and the elderly.

Career Highlights: Rajesh has had an illustrious career, having worked with prominent organizations such as Pfizer Corporation and the University of British Columbia. His experience at these institutions has significantly contributed to his expertise in research and innovation in the field of immunology.

Collaborations: Throughout his career, Rajesh Kumar Kainthan has collaborated with talented individuals, including Avvari Krishna Prasad and Jin-Hwan Kim. These collaborations reflect a collective effort towards advancing research and creating impactful innovations in health sciences.

Conclusion: Rajesh Kumar Kainthan stands out in the realm of invention with his substantial contributions to immunology and vaccine development. His innovative patents are poised to play a pivotal role in enhancing public health initiatives and combating infectious diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…